🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
This pilot clinical trial studies the side effects and best dose of ruxolit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2016-11-13
Trial ID
NCT02917096
This single-center, uncontrolled pilot study aims to evaluate the efficacy,...
Status
Completed
Location
Karolinska University Hospital Memory clinic
Start Date
2023-09-01
Trial ID
NCT06022068
Treatments Being Tested
The purpose of the study is to assess the effect of multiple doses of isavu...
Status
Completed
Location
Covance
Start Date
2011-11
Trial ID
NCT01809860
Treatments Being Tested
Aging can be defined as a time-dependent functional decline in physiologica...
Status
Active Not Recruiting
Location
AIM for Wellbeing
Start Date
2025-02-15
Trial ID
NCT07354620
Treatments Being Tested
This phase II trial studies how well everolimus and hormone therapy work in...
Status
Terminated
Location
Emory University Hospital Midtown
Start Date
2014-11-25
Trial ID
NCT02269670
Treatments Being Tested
Neuroendocrine tumors are rare but recent data showed a relevant increase i...
Status
Unknown
Location
Instituto do Cancer do Estado de São Paulo
Start Date
2014-03
Trial ID
NCT02279758
Treatments Being Tested
This research is planned to illustrate the efficacy and safety of sirolimus...
Status
Unknown
Location
Faculty of Medicine, Alexandria university, Egypt
Start Date
2020-08-15
Trial ID
NCT04461340
Treatments Being Tested
The purpose of this phase II study is to assess the efficacy of AP23573 in ...
Status
Completed
Location
University of Chicago Hospitals, Section of Hematology/Oncology
Start Date
2004-06
Trial ID
NCT00086125
Treatments Being Tested
This is an open label, two-part study of temsirolimus given as a 60-minute ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00106353
Treatments Being Tested